Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 416 shares at $61.20 ($25K) on 2021-02-19, disclosed to the SEC on 2021-03-03.
Scheduled sale ($25k) by Chief Business Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |